These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34188467)

  • 21. Suboptimal Peak Inspiratory Flow and Critical Inhalation Errors are Associated with Higher COPD-Related Healthcare Costs.
    Leving MT; van Boven JFM; Bosnic-Anticevich SZ; van Cooten J; Correia de Sousa J; Cvetkovski B; Dekhuijzen R; Dijk L; García Pardo M; Gardev A; Gawlik R; van der Ham I; Hartgers-Gubbels ES; Janse Y; Lavorini F; Maricoto T; Meijer J; Metz B; Price DB; Roman-Rodríguez M; Schuttel K; Stoker N; Tsiligianni I; Usmani OS; Kocks JH
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2401-2415. PubMed ID: 36185173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and COPD phenotype for a suboptimal peak inspiratory flow rate against the simulated resistance of the Diskus® dry powder inhaler.
    Mahler DA; Waterman LA; Gifford AH
    J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):174-9. PubMed ID: 23025451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhalation characteristics of asthma patients, COPD patients and healthy volunteers with the Spiromax® and Turbuhaler® devices: a randomised, cross-over study.
    Azouz W; Chetcuti P; Hosker H; Saralaya D; Chrystyn H
    BMC Pulm Med; 2015 May; 15():47. PubMed ID: 25927483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers.
    W H Kocks J; Wouters H; Bosnic-Anticevich S; van Cooten J; Correia de Sousa J; Cvetkovski B; Dekhuijzen R; Dijk L; Dvortsin E; Garcia Pardo M; Gardev A; Gawlik R; van Geer-Postmus I; van der Ham I; Harbers M; de la Hoz A; Janse Y; Kerkhof M; Lavorini F; Maricoto T; Meijer J; Metz B; Price D; Roman-Rodriguez M; Schuttel K; Stoker N; Tsiligianni I; Usmani O; Leving MT
    NPJ Prim Care Respir Med; 2022 May; 32(1):18. PubMed ID: 35618739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced Peak Inspiratory Effort through the Diskus((R)) and the Turbuhaler((R)) due to Mishandling is Common in Clinical Practice.
    Melani AS; Bracci LS; Rossi M
    Clin Drug Investig; 2005; 25(8):543-9. PubMed ID: 17532698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of Turbuhaler((R)) in Patients with Acute Airway Obstruction and COPD, and in Children with Asthma : Understanding the Clinical Importance of Adequate Peak Inspiratory Flow, High Lung Deposition, and Low In Vivo Dose Variability.
    Selroos O; Borgström L; Ingelf J
    Treat Respir Med; 2006; 5(5):305-15. PubMed ID: 16928144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient Inspiratory Maneuver Performance; Peak Lungpower, Acceleration and Volume.
    Haikarainen J; Vahteristo M; Lähelmä S; Vartiainen V; Malmberg LP
    J Aerosol Med Pulm Drug Deliv; 2020 Dec; 33(6):305-313. PubMed ID: 32423277
    [No Abstract]   [Full Text] [Related]  

  • 28. The relationship between peak inspiratory flow and hand grip strength measurement in men with mild chronic obstructive pulmonary disease.
    Tsuburai T; Komase Y; Tsuruoka H; Oyama B; Muraoka H; Hida N; Kobayashi T; Matsushima S
    BMC Pulm Med; 2022 Feb; 22(1):65. PubMed ID: 35177056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The inhalation characteristics of patients when they use different dry powder inhalers.
    Azouz W; Chetcuti P; Hosker HS; Saralaya D; Stephenson J; Chrystyn H
    J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):35-42. PubMed ID: 24815999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the Effectiveness of Written Dry Powder Inhaler Instructions and Health Literacy in Subjects Diagnosed With COPD.
    Alsomali HJ; Vines DL; Stein BD; Becker EA
    Respir Care; 2017 Feb; 62(2):172-178. PubMed ID: 28028187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding Dry Powder Inhalers: Key Technical and Patient Preference Attributes.
    Levy ML; Carroll W; Izquierdo Alonso JL; Keller C; Lavorini F; Lehtimäki L
    Adv Ther; 2019 Oct; 36(10):2547-2557. PubMed ID: 31478131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Suboptimal Peak Inspiratory Flow in Patients with Stable COPD.
    Represas-Represas C; Aballe-Santos L; Fernández-García A; Priegue-Carrera A; López-Campos JL; González-Montaos A; Botana-Rial M; Fernández-Villar A
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33291438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients with asthma or chronic obstructive pulmonary disease (COPD) can generate sufficient inspiratory flows via Easyhaler
    Malmberg LP; Pelkonen AS; Vartiainen V; Vahteristo M; Lähelmä S; Jõgi R
    J Thorac Dis; 2021 Feb; 13(2):621-631. PubMed ID: 33717535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of peak inspiratory flow with in-check dial device to simulate low-resistance (Diskus) and high-resistance (Turbohaler) dry powder inhalers in children with asthma.
    Amirav I; Newhouse MT; Mansour Y
    Pediatr Pulmonol; 2005 May; 39(5):447-51. PubMed ID: 15765541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suboptimal peak inspiratory flow rate: a noticeable risk factor for inhaler concordance in patients with chronic airway diseases.
    Meng W; Xiong R; Zhao Z; Zeng H; Chen Y
    BMJ Open Respir Res; 2024 Apr; 11(1):. PubMed ID: 38642917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inspiratory flow profile and usability of the NEXThaler, a multidose dry powder inhaler, in asthma and COPD.
    Chetta A; Yorgancioglu A; Scuri M; Barile S; Guastalla D; Dekhuijzen PNR
    BMC Pulm Med; 2021 Feb; 21(1):65. PubMed ID: 33632183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults.
    Melani AS; Zanchetta D; Barbato N; Sestini P; Cinti C; Canessa PA; Aiolfi S; Neri M;
    Ann Allergy Asthma Immunol; 2004 Nov; 93(5):439-46. PubMed ID: 15562882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dry powder inhalers: which factors determine the frequency of handling errors?
    Wieshammer S; Dreyhaupt J
    Respiration; 2008; 75(1):18-25. PubMed ID: 17911976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary disease.
    Loh CH; Ohar JA
    Curr Opin Pulm Med; 2024 Mar; 30(2):174-178. PubMed ID: 38164804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity matters.
    Malmberg LP; Rytilä P; Happonen P; Haahtela T
    Int J Chron Obstruct Pulmon Dis; 2010 Aug; 5():257-62. PubMed ID: 20714380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.